Gene therapy shows promising results against multiple myeloma
This study is now enrolling patients at Providence Cancer Institute – the only site outside of Australia.
Read Article
-
-
Q&A: Colon cancer in younger adults, when to screen, symptoms and prevention
Dr. Kelly Perlewitz answers timely questions about the rise of colon cancer cases in younger adults.
Read Article
-
Celebrating oncology social workers: Compassion, expertise and impact
We celebrate the work of oncology social workers, whose work is essential, transformative and deeply human.
Read Article
-
6 things everyone should know about oncology palliative care
Palliative care can help manage pain, fatigue, anxiety and so much more – at any stage of cancer treatment.
Read Article
-
Clinical trial seeks better first-line therapy for follicular lymphoma
The study may redefine care for many people at the earliest stage of their treatment.
Read Article
-
Where curiosity meets impact: Women in science at Providence Cancer Institute
Get to know the women of the Immune Monitoring Laboratory and how their curiosity, tenacity and passion are driving progress in cancer research at Providence Cancer Institute.
Read Article
-
Why patients in rural areas need access to quality clinical trials
Dr. Natasha Edwin advocates for making more quality clinical trials available for patients in rural communities.
Read Article
-
A new strategy for treating locally advanced cervical cancer
A new study aims to move cervical cancer care forward and improve the chance of long-term remission for more patients.
Read Article
-
Personalizing lymphoma treatment: New study seeks better outcomes
A targeted therapy being evaluated in a clinical trial may improve survival for high-risk patients with diffuse large B-cell lymphoma.
Read Article
-
From patient to volunteer: Marge’s gift of gratitude
Marge received treatment for pancreatic cancer at Providence Cancer Institute and then volunteered in the infusion center to help the care team that supported her.
Read Article
-
Reflecting on 2025, building toward 2026
Catch the 2025 highlights from Providence Cancer Institute in this year-end recap focused on research advancements, caregiver recognition and community engagement.
Read Article
-
Introducing Prevention4ME: A new era in breast cancer risk assessment and early detection
Providence Breast Care and Breast Surgery Clinics launch Prevention4ME, a groundbreaking program to empower women with personalized breast cancer risk assessments and proactive screening options.
Read Article
-
A precision oncology revolution is underway at Providence
Celebrating World Cancer Day with a look at the work of Carlo Bifulco, M.D. as he helps lead advancements in AI-driven, accessible precision oncology at Providence Cancer Institute.
Read Article
-
2025 SITC Meeting: Three Providence researchers honored at 40th anniversary
Providence Cancer Institute researchers share important cancer research at SITC annual meeting and receive recognition for their contributions to science.
Read Article
-
Oncology Lecture Series: The state of lung cancer screening and thoracic robotic surgery with Dr. Areo Saffarzadeh
Thoracic surgeon and director of Robotic Thoracic Surgery at Providence Cancer Institute shares the latest in lung cancer screening and treatment approaches.
Read Article
-
Transforming outcomes in AML and breast cancer: Three open trials at Providence
New studies at Providence Cancer Institute offer hope to patients with limited treatment options.
Read Article
-
Oregon cancer leaders unite to discuss research and policy
Providence Cancer Institute leader joined experts in cancer research, policy and advocacy to discuss current challenges and the future of research.
Read Article
-
Lobular Breast Cancer: Exploring Current Knowledge and Advancing Understanding of This Understudied Disease.
Providence medical breast oncologist to give a special presentation on Lobular Breast Cancer and the latest data on the development of a lobular prevention vaccine.
Read Article
-
Next generation therapy for men with mCRPC may extend survival
A medication designed to block and break down the androgen receptor, a key driver of prostate cancer growth, is being evaluated in a clinical trial at Providence Cancer Institute.
Read Article
-
Behind the science: Celebrating our cancer research administrator
Get a behind the scenes peek into the work of a cancer research administrator as she reflects on her time at Providence Cancer Institute.
Read Article
-
Loading More...
